Management of an outbreak of peste des petits ruminants with antibiotic combined hyperimmune serum therapy
Keywords:goat, PPR virus, antibiotic, hyperimmune serum
Peste des petits ruminants (PPR) is a highly contagious viral disease associated with high morbidity and mortality in goats of Bangladesh. Though there is no known effective drug against PPR virus, Animal Health Research Division (AHRD), Bangladesh Livestock Research Institute (BLRI) has developed a treatment technology antibiotic combined hyperimmune serum therapy (ACHST) against the deadly PPR virus. This article described the management of a huge outbreak of PPR by ACHST at goat farm of BLRI regional station, Naikhongchari, Bandarban, a hilly area of Bangladesh. Seventy two goats out of 159 goats were infected with PPR virus naturally. The clinical history and necropsy findings were recorded and nasal swabs were collected for diagnosis of PPR virus by RT-PCR. Thirty goats among 72 goats were died before providing treatment and the rest alive 42 goats were received ACHST. Each of the goats was treated with PPR specific hyperimmune serum @ 4-5ml/goat slow IV for once, Amcicoli-D (Ampicillin trihydrate, Colistin sulfate and Dexamethasone acetate) @ 1ml/10kg body weight daily IM once for 3 days and metronidazole @ 500mg/35kg body weight orally thrice daily for 3 days. After treatment, 38 goats (93.23%) were recovered out of 42 goats. The comparative evaluation of ACHST at different stages of naturally PPR infected goats shown highest recovery rate in incubation (100%) and prodromal (100%) phases followed by pneumonic (91.67%) and diarrhoeal (81.25%) phases. It may be concluded that the ACHST could be used as therapeutic interventions for PPR infected goats.
Asian J. Med. Biol. Res. June 2015, 1(2): 230-234
How to Cite
Authors who publish with this journal agree to the following terms / The author(s) affirm(s) that:
- The manuscript submitted is based on authors own research and is original work.
- Authors certify that we all participated in the research work and preparation of the manuscript in a substantive way.
- Authors also declare that they have read and approved the manuscript.
- Authors further declare that the manuscript has not been published in part or full and is not being submitted or considered for publication in part or full elsewhere.
- Any material included in the manuscript does not violate copyright or other rights of anyone.
- Authors also affirm that the article contains no vilifying or unlawful statements and does not contain material or instructions that might cause harm or injury to the Editor-in-Chief/Editors of the Journal and the public.
- Authors assure Asian J. Med. Biol. Res. and the Editor-in-Chief/Editors of the Journals, and hold them harmless from any loss, expense or damage occurred by a claim or suit by a third party for copyright violation, or any suit arising out of any violation of the foregoing warranties as a result of publication of my/our article.
- In consideration of authors manuscript submitted, authors hereby grant Asian J. Med. Biol. Res. unlimited, worldwide, permanent royalty-free, right to publish, use, dispense, license, transmit, display, exhibit, record, store, translate, digitize, broadcast, reproduce and archive, in any format or medium, whether now known or developed hereafter.
All materials related to manuscripts, accepted or rejected, including photographs, original figures etc., will be kept by Asian J. Med. Biol. Res. for one year following the editors decision. These materials will then be destroyed.